Explore the Global Cell and Gene Therapy Manufacturing Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Cell and Gene Therapy Manufacturing Market

Key Insight

Cell and gene therapy manufacturing sales will grow through 2036, led by gene therapy manufacturing at 63.9% of the therapy type segment in 2026. The market was valued at USD 32.12 billion in 2025 and is expected to be worth USD 336.25 billion by 2036, creating an incremental opportunity of USD 296.49 billion.

April 28, 2026

Anurag Sharma

250 Pages

Cite this Report

Cell and Gene Therapy Manufacturing Market

https://www.futuremarketinsights.com/reports/cell-and-gene-therapy-manufacturing-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

BlueRock Therapeutics (Bayer)
Catalent Inc
FUJIFILM Diosynth Biotechnologies Limited
Lonza
Miltenyi Biotec
Minaris Regenerative Medicine
Samsung Biologics
Thermo Fisher Scientific Inc.
Vigene Biosciences
WuXi Advanced Therapies Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Cell and Gene Therapy Manufacturing Market

Key Players

Similar Industry Reports